Image

Evaluation of a Targeted Magnetic Resonance Imaging Contrast Agent in Prostate Cancer Patients

We are studying a new MRI contrast agent for prostate cancer.

Recruiting
18-90 years
Male
Phase 1/2
  • Simplified description (AI rewritten)
  • Technical description (Original)

Study Purpose: This research is to test a new MRI contrast agent called MT218 in men with prostate cancer. A contrast agent is a special dye that helps doctors see organs better in images. The study aims to see if MT218 can better identify aggressive prostate cancer compared to current imaging methods.

Study Details: This is a Phase 1b study, meaning it's an early stage of clinical research. It's an open-label study, so both doctors and patients know the treatment given. Researchers will increase doses to test safety and effectiveness. Eligible participants are men over 18 with a high Gleason score (8-10) prostate cancer. Participants must be able to stay still for MRI scans and meet specific health criteria.

  • **Duration and Visits:** Specific visit details are not provided. Participation involves imaging and medical assessments.
  • **Safety:** All participants will be monitored closely for any side effects from the new contrast agent.
  • **Compensation/Risks:** Compensation details aren't specified, but potential risks include MRI-related issues.

If you are interested, please ensure you meet the criteria and discuss with your doctor.

Print
Study details
    MRI Scan

NCT06262139

Songqi Gao

31 March 2025

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.